Redsense Medical signs collaboration agreement with University Health Network in Toronto, Canada, for study with Redsense Clamp
Redsense Medical has signed a collaboration agreement with University Health Network in Toronto, Canada, to conduct a study with Redsense Clamp, an accessory to the company’s alarm system that can automatically stop the blood flow when blood leakage is detected, independent from the dialysis machine. The study includes home dialysis patients and will be conducted during the second through the forth quarter of 2018.
The University Health Network, that conducts research and healthcare at six different hospitals and treatment centres in Toronto, is a recognized leader in home hemodialysis care. Dr Christopher Chan, the Medical Director of the Home Hemodialysis Unit at the University Health Network and a recognized expert in the field, will be leading the study.
"It is encouraging to be able to present our collaboration with Dr Christopher Chan and the University Health Network. Dr Chan has been instrumental in the process of designing Redsense Clamp from the concept stage to the prototype version that will be used in the study, and their dialysis centre is an excellent reference clinic for world-leading home hemodialysis care. I am convinced that both parties will be able to benefit greatly from this collaboration", says Redsense Medical’s CEO Patrik Byhmer.
After the completion of the study in the third quarter of 2018, a final version of Redsense Clamp will be developed. This product will then be available through Redsense Medical's distributors.
For more information, please contact
Patrik Byhmer, CEO Redsense Medical AB (publ)
Telephone: +46 (0) 35 - 10 60 30
Email: patrik.byhmer@redsensemedical.com
Website: www.redsensemedical.com
About Redsense Medical
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense system, a medical technology product used for monitoring and alarm in the case of blood leakage in connection with hemodialysis. Redsense solves one of the most serious remaining safety problems within hemodialysis – to quickly detect venous needle dislodgement and catheter leakage and minimizing blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. The company has also developed an internationally standardized direct connection enabling compatible dialysis machines to stop the blood flow automatically when blood leakage occurs. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.